SAB Biotherapeutics, Inc. (SABS) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
SAB Biotherapeutics, Inc. (SABS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $37.9M, listed on NASDAQ, employing roughly 63 people, carrying a beta of 0.56 to the broader market. SAB Biotherapeutics, Inc. Led by Samuel J. Reich, public since 2021-02-09.
Snapshot as of May 15, 2026.
- Spot Price
- $3.67
- ATM IV
- 176.3%
- IV Skew 25Δ
- -1.643
- Term Structure Slope
- -0.356
As of May 15, 2026, SAB Biotherapeutics, Inc. (SABS) at-the-money implied volatility is 176.3%. The 25-delta skew is -1.643: puts carry meaningful premium over calls, a classic equity downside-protection skew. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
SABS Strategy Selection at Current Volatility Levels
For SAB Biotherapeutics, Inc. options at 176.3% ATM IV, mid-range IV rank is the regime where directional conviction matters more than vol-regime positioning; strategy choice should follow the event calendar and the dealer-positioning view rather than IV rank alone. The 25-delta skew is meaningfully put-skewed, so put-credit spreads capture more premium for the same width than call-credit spreads. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked SABS volatility skew questions
- What is the current SABS ATM implied volatility?
- As of May 15, 2026, SAB Biotherapeutics, Inc. (SABS) at-the-money implied volatility is 176.3%. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is SABS IV high or low historically?
- Strategy choice depends on whether IV is rich or cheap relative to history; consult IV rank alongside the absolute level.
- What does SABS volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. SAB Biotherapeutics, Inc. carries the typical equity downside-protection skew: 25-delta puts price meaningfully richer than 25-delta calls. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.